Table 3

Summary of five patients with progression of MMD

CasesAge/sexVascular risk factorsInitial clinical manifestationsSuzuki stage
(initial DSA)
PCA-ACA
(initial DSA)
PCA-MCA
(initial DSA)
No of mons btwn initial to second DSASuzuki stage
(second DSA)
PCA-ACA
(initial DSA)
PCA-MCA
(initial DSA)
119/FIVHL(3)R(0)L(2)R(1)L(4)R(1)100L(3)R(1)L(2)R(2)L(4)R(3)
235/FHPTIAL(5)R(0)L(2)R(1)L(4)R(0)137L(5)R(5)L(2)R(1)L(4)R(1)
310/FTIAL(3)R(4)L(2)R(2)L(1)R(3)29L(4)R(4)L(2)R(2)L(3)R(3)
428/MStrokeL(2)R(0)L(1)R(0)L(1)R(0)4L(4)R(0)L(1)R(0)L(1)R(0)
532/FTIAL(3)R(0)L(0)R(0)L(1)R(0)37L(4)R(0)L(0)R(0)L(1)R(0)
  • ACA, anterior cerebral artery; DSA, digital subtraction angiography; F, female; HP, hypertension; IVH, intraventricular haemorrhage; M, male; MCA, middle cerebral artery; MMD, moyamoya disease; PCA, posterior cerebral artery; TIA, transient ischaemic attack.